Target expression details
Target's General Information | |||||
---|---|---|---|---|---|
Target ID | T86652 | ||||
Target Name | PCSK9 messenger RNA (PCSK9 mRNA) | ||||
Synonyms | Subtilisin/kexin-like protease PC9 (mRNA); Proprotein convertase subtilisin/kexin type 9 (mRNA); Proprotein convertase 9 (mRNA); PSEC0052 (mRNA); PC9 (mRNA); Neural apoptosis-regulated convertase 1 (mRNA); NARC1 (mRNA); NARC-1 (mRNA) | ||||
Target Type | Successful | ||||
Gene Name | PCSK9 | ||||
Biochemical Class | mRNA target | ||||
UniProt ID | PCSK9_HUMAN | ||||
Target's Expression Profile in Disease Related Tissue between Patients and Normal People | |||||
Disease | Coronary artery disease | ||||
Example drug | BMS-PCSK9 | Preclinical | [1], [2] | ||
Tissue | Peripheral blood | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: -0.13 Z-score: -0.62 P-value: 9.13E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Disease | Familial hypercholesterolemia | ||||
Example drug | ALN-PCS | Preclinical | [2], [3] | ||
Tissue | Whole blood | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: -0.07 Z-score: -0.3 P-value: 4.82E-02 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
References | |||||
REF 1 | Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011). | ||||
REF 2 | NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. | ||||
REF 3 | Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals, Inc (2011). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.